Deals Of The Week: Pfizer Leads The Action Even After Wyeth Purchase
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Takeover gives Vertex two clinical-stage polymerase inhibitors, and recalls Gilead’s key Triangle grab.
U.S. co-promotion will combine sales forces to promote Pfizer’s Xalatan and Bausch & Lomb’s Alrex, Lotemex, Zylet and besifloxacin.
Deal with the Indian pharma company Aurobindo highlights the giant’s interest in expanding its product mix.